Bjornsdottir
Marta Bjornsdottir, Reykjavik IS
Patent application number | Description | Published |
---|---|---|
20130173023 | PROSTHETIC FOOT WITH RESILIENT HEEL - A prosthetic foot can include a resilient heel member that can be removably coupled to the bottom of a plate-like foot member of the prosthetic foot. The heel member can be made of a resilient material, such as foam. The heel member can have a shape that corresponds to a foot cover and allows the prosthetic foot to fit within a foot cover. A lip may be provided to engage with a corresponding portion of the foot cover to secure the heel member within the foot cover. A rib can be located on the bottom of the heel member to create horizontal or vertical displacement of the foot at heel strike. A recess can be created in the heel member to removably receive an insert, which can alter the stiffness of the heel member. | 07-04-2013 |
Unnur S. Bjornsdottir, Seltjamarnes IS
Patent application number | Description | Published |
---|---|---|
20100160802 | Genetic Variants as Markers for Use in Diagnosis, Prognosis and Treatment of Eosinophilia, Asthma, and Myocardial Infarction - Polymorphic variants (e.g., certain alleles of polymorphic markers) that have been found to be associated with high blood eosinophil counts, conditions causative of eosinophilia (e.g., asthma, myocardial infarction), and/or hypertension are provided herein. Such polymorphic markers are useful for diagnostic purposes, such as in methods of determining a susceptibility, and for prognostic purposes, including methods of predicting prognosis and methods of assessing an individual for probability of a response to a therapeutic agent, as further described herein. Further applications utilize the polymorphic markers of the invention include, screening methods and genotyping methods. The invention furthermore provides related kits, computer-readable medium, and apparatus. | 06-24-2010 |
Unnur Steina Bjornsdottir, Seltjarnarnes IS
Patent application number | Description | Published |
---|---|---|
20130253847 | GENETIC VARIANTS AS MARKERS FOR USE IN DIAGNOSIS, PROGNOSIS AND TREATMENT OF EOSINOPHILIA, ASTHMA, AND MYOCARDIAL INFARCTION - Polymorphic variants (e.g., certain alleles of polymorphic markers) that have been found to be associated with high blood eosinophil counts, conditions causative of eosinophilia (e.g., asthma, myocardial infarction), and/or hypertension are provided herein. Such polymorphic markers are useful for diagnostic purposes, such as in methods of determining a susceptility, and for prognostic purposes, including methods of predicting prognosis and methods of assessing an individual for probability of a response to a therapeutic agent, as further described herein. Further applications utilize the polymorphic markers of the invention include, screening methods and genotyping methods. The invention furthermore provides related kits, computer-readable medium, and apparatus. | 09-26-2013 |